Shop Research About Compliance Affiliate Free Consultation

Cagrilintide

Long-Acting Amylin Analog

Amylin receptor agonist. Studied alongside GLP-1 compounds in metabolic models.

✓ HPLC Verified ✓ 99%+ Purity ✓ COA Available ✓ Ships in 24hr ✓ US-Based ✓ Direct Support
📋 Certificate of Analysis Request COA via Telegram
Cagrilintide research peptide vial
Select Size
$265
10-vial kit
+ $40 shipping · Free over $1,000 per tier · US: 2-5 day UPS · Intl: 7-14 day
✓ Added to cart View Cart →
Research Data

What Is Cagrilintide?

Cagrilintide is a long-acting amylin analog developed by Novo Nordisk. Amylin is a pancreatic peptide that reduces appetite and slows gastric emptying through central nervous system pathways distinct from GLP-1. Combined with semaglutide (CagriSema), it demonstrated up to 22.7% weight reduction in phase 2 trials.

Research Context

  • Amylin receptor agonism and hypothalamic appetite signaling
  • Combination with GLP-1 agonists for additive appetite suppression (CagriSema trials)
  • Gastric emptying modulation and postprandial glucose control
  • Dual-pathway weight management research vs single-agent approaches

Storage & Reconstitution

Store lyophilized at -20°C. Reconstituted: refrigerate 2–8°C, use within 4–6 weeks.

All products sold for research purposes only. Not for human or animal consumption. Must be 21 or older to purchase. By placing an order you confirm compliance with all applicable local laws and regulations.